STUDIES ON SUSTAINED-RELEASE .11. LIPID GRANULES OF SULFAMETHIZOLE

被引:2
作者
OZDEMIR, AN
AGABEYOGLU, IT
机构
[1] GAZI UNIV,FAC PHARM,DEPT PHARMACEUT TECHNOL,ETILER 06330,TURKEY
[2] UNIV ANKARA,FAC PHARM,DEPT PHARMACEUT TECHNOL,TANDOGAN 06100,TURKEY
关键词
D O I
10.3109/03639049009025788
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to prepare a sustained release granule of sulfamethizole, employing hydrogenated castor oil (Cutina HR). After the dosage form design was made, different formulations were prepared as granules by the fusing technique. The granules manufactured were analysed with sieves between 0.5 and 1 mm openings. The fractions obtained were tested for dissolution rate for a period of seven hours with fluids of varying pHs with the continuous flow-through cell apparatus. Upon the kinetic evaluation of dissolution data, it was seen that the target release rates were achieved. The results showed that, the drug release rates increase with increasing amounts of PEG 4000 added to the formulations; up to a certain percentage. No increase beyond this point was noticed. The drug release rates mostly followed zero-order and modified Hixson-Crowell kinetics. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:1805 / 1814
页数:10
相关论文
共 19 条
[1]   STUDIES ON SUSTAINED-RELEASE .4. INERT MATRIX TABLETS OF SULFAMETHIZOLE, EMPLOYING POLYVINYL-CHLORIDE AND CARBOXYPOLYMETHYLENE [J].
AGABEYOGLU, IT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (04) :569-576
[4]  
AGABEYOGLU IT, 1981, NATIONAL PHARMACEUTI
[5]  
AGABEYOGLU IT, 1989, 49TH INT C PHARM SCI
[8]   Dependence of reaction velocity upon surface and agitation II - Experimental procedure in study of surface [J].
Hixson, AW ;
Crowell, JH .
INDUSTRIAL AND ENGINEERING CHEMISTRY, 1931, 23 :1002-1009
[9]   Dependence of reaction velocity upon surface and agitation I - Theoretical consideration [J].
Hixson, AW ;
Crowell, JH .
INDUSTRIAL AND ENGINEERING CHEMISTRY, 1931, 23 :923-931
[10]  
KAYNAROZDEMIR AN, 1988, STP PHARM, V4, P656